Creative Planning - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$8,468,000
+59.7%
365,367
+9.4%
0.03%
+50.0%
Q1 2018$5,302,000
-27.9%
334,012
-5.6%
0.02%
-31.2%
Q4 2017$7,349,000
+26.3%
353,656
-12.9%
0.03%
+18.5%
Q3 2017$5,818,000
-10.5%
405,993
+7.7%
0.03%
-18.2%
Q2 2017$6,500,000
+55.2%
377,066
-1.9%
0.03%
+43.5%
Q1 2017$4,187,000
-31.6%
384,522
-9.0%
0.02%
-37.8%
Q4 2016$6,124,000
-8.8%
422,755
+53.3%
0.04%
-14.0%
Q3 2016$6,717,000
+42.5%
275,820
+16.8%
0.04%
+26.5%
Q2 2016$4,714,000
+14.6%
236,055
+34.7%
0.03%
+6.2%
Q1 2016$4,113,000
-30.0%
175,259
+201.6%
0.03%
-33.3%
Q4 2015$5,879,000
-50.2%
58,110
-12.1%
0.05%
-53.8%
Q3 2015$11,796,000
-18.1%
66,131
+2.0%
0.10%
-20.6%
Q2 2015$14,405,000
+10.6%
64,844
-1.1%
0.13%
+7.4%
Q1 2015$13,022,000
+38.7%
65,561
-1.5%
0.12%
+24.5%
Q4 2014$9,388,000
+10.5%
66,571
+1.3%
0.10%0.0%
Q3 2014$8,493,000
+3.5%
65,698
-0.4%
0.10%
-7.5%
Q2 2014$8,203,000
-3.9%
65,982
+0.5%
0.11%
-17.2%
Q1 2014$8,532,000
+116.3%
65,627
+95.3%
0.13%
+91.0%
Q4 2013$3,945,000
+1102.7%
33,599
+969.7%
0.07%
+857.1%
Q3 2013$328,000
+28.1%
3,141
+5.7%
0.01%
+16.7%
Q2 2013$256,0002,9710.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders